Influenza Vaccines Market projected to exceed $6 Billion by 2025
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
Pharmaceuticals, Biotechnology and Life Sciences
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
NanoFlu vaccine was well tolerated over the three-week trial period, Novavax said Thursday, adding it now expects to begin a…
Faron Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for Traumakine, which also has…
BD said on Wednesday that its BD Veritor System Flu A+B, a digital immunoassay for the rapid detection of influenza, meets the new Food and Drug Administration’s (FDA’s) performance requirements.
Flu, or influenza, is a very contagious, acute, viral respiratory infection. Influenza viruses vary in a high degree. The extent…